Type 2 Diabetes Surgery

What metabolic surgery is

Type 2 diabetes surgery is the use of established bariatric operations with the improvement of blood glucose control as the primary objective rather than a by-product. In the literature it is usually called metabolic surgery. The aim is not simply to reduce weight but to act on the mechanisms that regulate glucose metabolism.

The rationale comes from how closely type 2 diabetes and obesity are linked. Excess adipose tissue drives insulin resistance, and insulin resistance makes glucose harder to control. Weight loss loosens that chain, as one would expect — but the effect of metabolic surgery reaches beyond weight loss, and in some patients glycaemic control begins to improve before any substantial weight has been lost.

How the operation affects blood glucose

Changing the route food takes through the digestive tract also changes the pattern of hormone release from the gut. Shifts in incretin hormones such as GLP-1 influence insulin secretion and how tissues respond to insulin. Changes in hunger-related hormones affect appetite and food choice at the same time.

How much these mechanisms achieve differs from patient to patient. How long diabetes has been present, whether insulin is being used, and how much insulin-producing capacity the pancreas retains all shape the outcome. That is why endocrine assessment and specific blood tests precede any decision. No one can be promised a defined result or the complete withdrawal of medication; the goal is better control of blood glucose.

Who is a candidate

International guidelines list metabolic surgery as a treatment option for patients with type 2 diabetes and a BMI of 35 or above, and as something to consider in selected patients with a BMI between 30 and 34.9 whose glucose remains inadequately controlled despite medication and lifestyle measures. At a BMI of 40 or above, surgery is already on the table under the criteria for obesity itself.

Type 1 diabetes is not an indication for these operations, because the underlying problem is different. Where diabetes has been present for many years, has become insulin-dependent, and pancreatic reserve is markedly reduced, the expected benefit falls. The decision weighs duration of diabetes, current medication, tests such as HbA1c and C-peptide, coexisting conditions and general fitness for surgery — and it cannot be made without examination.

• Type 2 diabetes with a BMI of 35 or above
• Selected patients with a BMI of 30–34.9 and inadequately controlled glucose
• Lifestyle measures and medication have not achieved target control
• Preserved pancreatic insulin reserve, assessed through blood tests
• Ability to commit to the long-term follow-up programme

Which operations are used

The two operations used most often for this purpose are sleeve gastrectomy and gastric bypass, both performed laparoscopically. In a sleeve gastrectomy, part of the stomach is removed to leave a narrow tube-shaped stomach. In a gastric bypass, a small gastric pouch is created and connected directly to the small intestine, altering the route food takes.

Which is preferred depends on the individual. Duration and severity of diabetes, BMI, reflux symptoms, current medication and any previous abdominal surgery all feed into the choice. Each operation has its own advantages and its own follow-up requirements, and the decision is made with the patient once the results of investigation are available.

Afterwards: medication, nutrition and monitoring

Because glucose control frequently changes after surgery, diabetes medication and insulin doses usually need to be adjusted. This is done together with your endocrinologist and guided by regular measurement. Stopping medication or changing doses without medical supervision is not safe.

Eating progresses in stages as it does after any bariatric operation, under dietitian supervision, and vitamin and mineral supplementation is tailored to the operation performed and monitored through blood tests. Follow-up is not only about weight: HbA1c, kidney function, retinal screening and foot care — the standard elements of diabetes care — continue after surgery as before.

Realistic expectations, and when to seek an assessment

Metabolic surgery is a significant treatment option in type 2 diabetes, but it cannot be presented as a cure. Some patients see marked improvement in glycaemic control and need less medication; others continue on treatment. Weight can be regained over the years and the disease can progress again, which is precisely why follow-up and lifestyle measures remain essential long after the operation.

If you have type 2 diabetes and your glucose is not reaching target despite medication, dietary change and exercise, it is reasonable to ask whether surgery is an option for you. At İzmir Cerrahi Merkezi that assessment is made together with endocrinology. The decision is individual to each patient and cannot be reached without examination, investigation and an unhurried conversation.